Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Direct Synthesis of Nano-Ferrierite along the 10-Ring-Channel Direction Boosts Their Catalytic Behavior.

Margarit VJ, Díaz-Rey MR, Navarro MT, Martínez C, Corma A.

Angew Chem Int Ed Engl. 2018 Mar 19;57(13):3459-3463. doi: 10.1002/anie.201711418. Epub 2018 Feb 27.

PMID:
29485242
2.

Unraveling the ultrafast behavior of nile red interacting with aluminum and titanium co-doped MCM41 materials.

Martin C, Cohen B, Navarro MT, Corma A, Douhal A.

Phys Chem Chem Phys. 2016 Jan 21;18(3):2152-63. doi: 10.1039/c5cp05855d. Epub 2015 Dec 22.

PMID:
26690671
3.

Direct Dual-Template Synthesis of MWW Zeolite Monolayers.

Margarit VJ, Martínez-Armero ME, Navarro MT, Martínez C, Corma A.

Angew Chem Int Ed Engl. 2015 Nov 9;54(46):13724-8. doi: 10.1002/anie.201506822. Epub 2015 Sep 18.

PMID:
26381669
4.

Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.

Feld JJ, Jacobson IM, Jensen DM, Foster GR, Pol S, Tam E, Jablkowski M, Berak H, Vierling JM, Yoshida EM, Perez-Gomez HR, Scalori A, Hooper GJ, Tavel JA, Navarro MT, Shahdad S, Kulkarni R, Le Pogam S, Nájera I, Eng S, Lim CY, Shulman NS, Yetzer ES.

J Hepatol. 2015 Feb;62(2):294-302. doi: 10.1016/j.jhep.2014.09.013. Epub 2014 Sep 18.

PMID:
25239078
5.

DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.

Everson G, Cooper C, Hézode C, Shiffman ML, Yoshida E, Beltran-Jaramillo T, Andreone P, Bruno S, Ferenci P, Zeuzem S, Brunda M, Le Pogam S, Nájera I, Zhou J, Navarro MT, Voulgari A, Shulman NS, Yetzer ES.

Liver Int. 2015 Jan;35(1):108-19. doi: 10.1111/liv.12471. Epub 2014 Feb 12.

PMID:
24517252
6.

Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.

Morcos PN, Moreira SA, Navarro MT, Bech N, Quatkemeyer A, Smith PF, Brennan BJ.

J Pharm Pharmacol. 2014 Jan;66(1):23-31. doi: 10.1111/jphp.12151. Epub 2013 Oct 10.

PMID:
24117531
7.

Effect of ritonavir-boosted danoprevir, a potent hepatitis C virus protease inhibitor, on the pharmacokinetics of methadone in healthy subjects undergoing methadone maintenance therapy.

Moreira SA, Morcos PN, Navarro MT, Bech N, Smith PF, Brennan BJ.

Pharmacotherapy. 2014 Mar;34(3):220-6. doi: 10.1002/phar.1341. Epub 2013 Aug 14.

PMID:
23946152
8.

Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Marcellin P, Cooper C, Balart L, Larrey D, Box T, Yoshida E, Lawitz E, Buggisch P, Ferenci P, Weltman M, Labriola-Tompkins E, Le Pogam S, Nájera I, Thomas D, Hooper G, Shulman NS, Zhang Y, Navarro MT, Lim CY, Brunda M, Terrault NA, Yetzer ES.

Gastroenterology. 2013 Oct;145(4):790-800.e3. doi: 10.1053/j.gastro.2013.06.051. Epub 2013 Jun 26.

PMID:
23811112
9.

Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin.

Brennan BJ, Moreira SA, Morcos PN, Navarro MT, Asthappan J, Goelzer P, Weigl P, Smith PF.

Clin Pharmacokinet. 2013 Sep;52(9):805-13. doi: 10.1007/s40262-013-0077-2.

PMID:
23712757
10.

Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover study.

Cirrincione-Dall G, Brennan BJ, Ballester-Sanchis RM, Navarro MT, Davies BE.

J Clin Pharmacol. 2012 Aug;52(8):1255-64. doi: 10.1177/0091270011412960. Epub 2011 Oct 30.

PMID:
22039289
11.

Modular organic structure-directing agents for the synthesis of zeolites.

Simancas R, Dari D, Velamazán N, Navarro MT, Cantín A, Jordá JL, Sastre G, Corma A, Rey F.

Science. 2010 Nov 26;330(6008):1219-22. doi: 10.1126/science.1196240.

12.

A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis.

Zhang X, Huang Y, Navarro MT, Hisoire G, Caulfield JP.

J Clin Pharmacol. 2010 Sep;50(9):1031-8. doi: 10.1177/0091270009357433. Epub 2010 Jan 25.

PMID:
20100913
13.

Reactivity in the confined spaces of zeolites: the interplay between spectroscopy and theory to develop structure-activity relationships for catalysis.

Boronat M, Concepción P, Corma A, Navarro MT, Renz M, Valencia S.

Phys Chem Chem Phys. 2009 Apr 28;11(16):2876-84. doi: 10.1039/b821297j. Epub 2009 Mar 13.

PMID:
19421502
14.

Direct synthesis of a photoactive inorganic-organic mesostructured hybrid material and its application as a photocatalyst.

Corma A, Navarro MT, Rey F, Ruiz VR, Sabater MJ.

Chemphyschem. 2009 May 11;10(7):1084-9. doi: 10.1002/cphc.200800724.

PMID:
19229898
15.

Synthesis of bifunctional Au-Sn organic-inorganic catalysts for acid-free hydroamination reactions.

Corma A, González-Arellano C, Iglesias M, Navarro MT, Sánchez F.

Chem Commun (Camb). 2008 Dec 14;(46):6218-20. doi: 10.1039/b810310k. Epub 2008 Oct 23.

PMID:
19082125
16.

A pilot study of ranolazine in patients with intermittent claudication.

Ma A, Garland WT, Smith WB, Skettino S, Navarro MT, Chan AQ, Anderson BE, Cooke JP.

Int Angiol. 2006 Dec;25(4):361-9.

PMID:
17164742
17.

Photochemical generation of electrons and holes in germanium-containing ITQ-17 zeolite.

Alvaro M, Atienzar P, Corma A, Ferrer B, Garcia H, Navarro MT.

J Phys Chem B. 2005 Mar 3;109(8):3696-700.

PMID:
16851409
19.

Preferential location of Ge atoms in polymorph C of beta zeolite (ITQ-17) and their structure-directing effect: a computational, XRD, and NMR spectroscopic study.

Sastre G, Vidal-Moya JA, Blasco T, Rius J, Jordá JL, Navarro MT, Rey F, Corma A.

Angew Chem Int Ed Engl. 2002 Dec 16;41(24):4722-6. No abstract available.

PMID:
12481338
20.

ITQ-16, a new zeolite family of the beta group with different proportions of polymorphs A, B and C.

Corma A, Navarro MT, Rey F, Valencia S.

Chem Commun (Camb). 2001 Sep 21;(18):1720-1.

PMID:
12240282
21.

Sn-MCM-41--a heterogeneous selective catalyst for the Baeyer-Villiger oxidation with hydrogen peroxide.

Corma A, Navarro MT, Nemeth L, Renz M.

Chem Commun (Camb). 2001 Nov 7;(21):2190-1.

PMID:
12240094
22.

Immunosuppressive therapy and post-transplantation diarrhea.

Pescovitz MD, Navarro MT.

Clin Transplant. 2001;15 Suppl 4:23-8. Review.

PMID:
11778784
24.

Pure Polymorph C of Zeolite Beta Synthesized by Using Framework Isomorphous Substitution as a Structure-Directing Mechanism.

Corma A, Navarro MT, Rey F, Rius J, Valencia S.

Angew Chem Int Ed Engl. 2001 Jun 18;40(12):2277-2280. doi: 10.1002/1521-3773(20010618)40:12<2277::AID-ANIE2277>3.0.CO;2-O.

PMID:
29711815
25.

Nitrite reductase mutants as an approach to understanding nitrate assimilation in Chlamydomonas reinhardtii.

Navarro MT, Guerra E, Fernández E, Galván A.

Plant Physiol. 2000 Jan;122(1):283-90.

26.

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, Hené RJ, Verpooten GA, Navarro MT, Hale MD, Nicholls AJ.

Transplantation. 1999 Jul 27;68(2):261-6.

PMID:
10440399
27.

Copying computer-generated-holographic interconnects by the use of partially coherent light.

Fimia A, Fuentes R, Pascual I, Beléndez A, Egozcue JJ, Navarro MT.

Appl Opt. 1994 Mar 10;33(8):1431-3. doi: 10.1364/AO.33.001431.

PMID:
20862168
28.

Solid-state NMR study of ordered mesoporous aluminosilicate MCM-41 synthesized on a liquid-crystal template.

Kolodziejski W, Corma A, Navarro MT, Pérez-Pariente J.

Solid State Nucl Magn Reson. 1993 Oct;2(5):253-9.

PMID:
7804777
29.

[THERAPEUTICS AND NONSPECIFIC IMMUNITY].

MULINASSARRION L, NAVARRO MT.

Prog Pediatr Pueric. 1964;7:526-8. Spanish. No abstract available.

PMID:
14246903

Supplemental Content

Loading ...
Support Center